全球羊水穿刺針市場 - 各針的種類、治療類型、終端用戶、地區 - 成長、趨勢、預測(2018年∼2023年)

全球羊水穿刺針市場，預計從2018年到2023年的CAGR(年複合成長率)為約5.4％。羊水檢驗，是妊娠中期採用羊水穿刺針採取包圍胎兒的羊水，診斷胎兒的異常。

本報告提供全球羊水穿刺針市場調查，市場概要，各針的種類、治療類型、終端用戶、地區的市場規模的變化與預測，市場趨勢，成長要素、阻礙因素以及市場機會、課題分析，競爭情形，主要企業的簡介等全面性資訊。

目錄

第1章 簡介

• 市場定義

第2章 調查方法

第3章 摘要整理

第4章 主要影響要素

第5章 市場概要

• 目前市場方案
• 波特的五力分析
  • 買方議價能力
  • 供給企業談判力
  • 新加入業者的威脅
  • 替代品的威脅
  • 競爭企業間的敵對關係

第6章 成長要素，阻礙因素，市場機會，課題

• 成長要素
  • 羊水檢驗的高可靠性
  • 第一胎年齡的中位數上升
  • 先天性病患的負擔
• 阻礙因素
  • 替代法的利用可能性
• 市場機會
• 主要課題

第7章 市場區隔

• 針的各類型
  • 100mm∼150mm
  • 151mm以上
  • 99mm以下
• 各治療類型
  • 羊水穿刺
  • 羊水消除
  • 胎兒輸血
  • 羊水補充
  • 臍帶穿刺
• 各終端用戶
  • 醫院
  • 診斷中心
  • 診療所
  • 其他
• 各地區
  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區

第8章 競爭情形

• M&A分析
• 協定，合作，夥伴關係
• 新產品的銷售

第9章 主要企業

• Becton, Dickinson and Company
• Biopsybell
• Cook Medical
• Coopersurgical
• Integra Lifesciences
• Laboratoire Ccd
• Medline
• Medtronic
• Ri.Mos.
• Rocket Medical
• Smiths Medical
• Tsunami Medical

第10章 市場未來展望

The market for amniocentesis is expected to grow steadily over the forecast period. Certain factors that are responsible for the growth of this market are the growing median age of first-time motherhood, the increasing burden of the congenital diseases, and the high reliability of people on amniocentesis.

Amniocentesis is almost 99.4% accurate and this test determines if the baby in the womb has any genetic or chromosomal abnormalities. The test can identify many genetic disorders, such as Down syndrome, Edward's syndrome, Tay-Sachs disease, Huntington's disease, sickle cell disease, and cystic fibrosis. It can provide the information needed to diagnosis these complications in the fetus. Due to the high reliability of the test, its adoption is good across several healthcare facilities, therefore the market is expected to expand over the forecast period.

Key Market Trends

Amniocentesis Procedure is Expected to Show Steady Growth Over the Forecast Period

Rising concern about genetic disorders is the major factor responsible for the growing number of procedures. Various studies have been conducted by organizations such as the National Institute of Health (NIH) to understand the risks associated with amniocentesis procedure and the challenges during the same. Studies have revealed that the occurrence of early abortion after amniocentesis is a major risk and its prevalence is around 10%. However, the technical advancements in the needles, and the focus of medical professionals on the safety of the patient, it is expected that the instances of early abortions will be reduced in the near future. Furthermore, the increasing birth rate globally is enhancing market growth. India is the leading country in terms of having the highest birthrate.

Therefore, due to the increasing birth rate, rising number of amniocentesis procedures, growing adoption of the same, and increasing focus on patient safety, the amniocentesis procedure segment is expected to show steady growth over the forecast period.

North America to Maintain Lead in the Amniocentesis Market

The global amniocentesis needle market is dominated by North America and Europe respectively. North America will continue to dominate the global market over the forecast period. Factors, such as the rising government initiatives and an increasing number of amniocentesis procedures, are driving the growth of the market in this region.

The developed healthcare system in the United States is augmenting the demand for advanced products which is accelerating the growth of amniocentesis needles with advanced technology. Added to that, a concern of the general population in the North America region about the genetic disorders in a newborn is propelling the demand for amniocentesis procedure.

Competitive Landscape

The market for amniocentesis needles is moderately competitive and is comprised mostly of local companies. Countries like China and India are having a large number of local suppliers for the amniocentesis needles which is posing an intense competition among these local companies. The market is also witnessing the presence of global companies but the competition among the big players is comparatively lower than that of the local players.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Deliverables
• 1.2 Study Assumptions
• 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 High Reliability of Amniocentesis
  • 4.2.2 Growing Median Age of First-Time Motherhood
  • 4.2.3 Increasing Burden of Congenital Disorders
• 4.3 Market Restraints
  • 4.3.1 Availability of Alternate Methods
  • 4.3.2 Lack of Skilled Professionals
• 4.4 Porter's Five Force Analysis
  • 4.4.1 Threat of New Entrants
  • 4.4.2 Bargaining Power of Buyers/Consumers
  • 4.4.3 Bargaining Power of Suppliers
  • 4.4.4 Threat of Substitute Products
  • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

• 5.1 By Type
  • 5.1.1 100 to 150 mm Needles
  • 5.1.2 Larger Than 150 mm Needles
  • 5.1.3 Smaller Than 100 mm Needles
• 5.2 By Procedure
  • 5.2.1 Amniocentesis Procedures
  • 5.2.2 Amnioreduction Procedures
  • 5.2.3 Fetal Blood Transfusion Procedures
  • 5.2.4 Amnioinfusion Procedures
  • 5.2.5 Cordocentesis Procedures
• 5.3 Geography
  • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
  • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
  • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
  • 5.3.4 Middle-East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle-East and Africa
  • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

• 6.1 Company Profiles
  • 6.1.1 The Ccoper Companis Inc.
  • 6.1.2 Becton, Dickinson and Company
  • 6.1.3 Cook Medical Incorporated
  • 6.1.4 RI.MOS. Srl
  • 6.1.5 Smiths Medical
  • 6.1.6 Laboratoire Ccd
  • 6.1.7 Integra Lifesciences
  • 6.1.8 Medtronic Plc
  • 6.1.9 Medline Industries Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS